UCSF Medical Center Ranks 1st Nationwide in Neuro, Among Top 10 Hospitals for 2021-22

UCSF Medical Center has been recognized as the nation’s best hospital for neurology and neurosurgery, and among the country’s premier medical centers overall, in the 2021-22 Best Hospitals survey by U.S. News & World Report. The rankings, released July 27, 2021, placed UCSF among the top 10

Thirteen Cancer Research Projects Funded in Spring 2021 RAP Cycle

Thirteen investigators were awarded grants in support of cancer research projects in the Spring 2021 cycle of the UCSF Resource Allocation Program (RAP). Funded by various agencies across UCSF, the awards span a range of topics from health equity to therapy resistance to developing new screening

HDFCCC Pledges Funds for Bold, Provocative Ideas

Cancer Center leadership is calling on members to submit their boldest ideas for future research projects and collaborations that will drive funding priorities and scientific emphasis over the coming decade. "Any one of our members or teams can lead the center in a new direction, and in turn, do the

Engineered Cells Successfully Treat Cardiovascular and Pulmonary Disease

Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are currently few viable options

Beyond CAR-T: New Frontiers in Living Cell Therapies

Our cells have abilities that go far beyond the fastest, smartest computer. They generate mechanical forces to propel themselves around the body and sense their local surroundings through a myriad of channels, constantly recalibrating their actions. The idea of using cells as medicine emerged with

An MD/PhD Collaboration to Apply Hyperpolarized 13 C Metabolic MRI for Assessing Renal Tumor Aggressiveness in Patients

Jane Wang, MD and Peder Larson, PhD, faculty members in the UC San Francisco Department of Radiology and Biomedical Imaging are collaborating on a project applying hyperpolarized (HP) carbon 13 (13C) metabolic MRI in patients with renal tumors. The overall goal of their study is to improve risk

Targeted Therapy for ‘Undruggable’ Lung Cancer Stems from Decades of UCSF Research

Over the past two decades, targeted cancer therapies have changed the prognosis for thousands of patients. By targeting the specific genetic mutation behind a patient’s cancer, these therapies have enabled increasing numbers of patients to experience fewer toxic side effects and, often, live free of